TABLE 7.
Strategy | Cost | LE | QALE | Incremental Costs* | Incremental Lys | Incremental QALYs | $/LY | 95% CI | $/QALY | 95% CI |
---|---|---|---|---|---|---|---|---|---|---|
CT | $3074 | 14.7386 | 10.9692 | $1631 | 0.0316 | 0.0201 | 52,000 | 34,000–106,000 | 81,000 | 52,000–186,000 |
Radiography | $1911 | 14.7071 | 10.9491 | $469 | 0 | 0 | Dom | Dom | ||
None† | $1443 | 14.7071 | 10.9491 | — | — | — | — | — |
Reprinted with permission from Black et al.6
Incremental costs are in reference to the None strategy because the Radiography strategy is dominated.
Cost in the None strategy includes diagnosis and treatment of lung cancer without LDCT or radiographic screening.
Dom indicates dominated.